Keith Adrian Powell

Oppilotech Ltd. engages in developing safe antibacterial compounds against drug resistant organisms. The company was founded by John George and Ajay Mistry on January 7, 2014 and is headquartered in London, the United Kingdom.

Longbow Capital LLP (Longbow Capital) is a private equity firm founded in 2004 by Jonathan Powell, Edward Beckett, Robin Finlayson, Kevin Doyle, Colin Bothway, Ron Petersen and Edward Rudd. The firm is headquartered in Norwich, United Kingdom.

Longbow Capital LLP (Longbow Capital) is a private equity firm founded in 2004 by Jonathan Powell, Edward Beckett, Robin Finlayson, Kevin Doyle, Colin Bothway, Ron Petersen and Edward Rudd. The firm is headquartered in Norwich, United Kingdom.

Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom.

Oppilotech Ltd. engages in developing safe antibacterial compounds against drug resistant organisms. The company was founded by John George and Ajay Mistry on January 7, 2014 and is headquartered in London, the United Kingdom.

Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom.

Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom.

Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom.

Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom.

Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom.

Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom.

Longbow Capital LLP (Longbow Capital) is a private equity firm founded in 2004 by Jonathan Powell, Edward Beckett, Robin Finlayson, Kevin Doyle, Colin Bothway, Ron Petersen and Edward Rudd. The firm is headquartered in Norwich, United Kingdom.

Oppilotech Ltd. engages in developing safe antibacterial compounds against drug resistant organisms. The company was founded by John George and Ajay Mistry on January 7, 2014 and is headquartered in London, the United Kingdom.